The new Clatterbridge Cancer Centre – Liverpool (CCC-L) is to open on 27 June and ensure the NHS in Cheshire and Merseyside is well placed to resume normal clinical activity by providing protected facilities for people with cancer, many of whom are particularly at risk if they catch coronavirus. It will also release capacity in other hospitals in the region.
The spectacular 11-storey cancer hospital in the heart of Liverpool’s Knowledge Quarter is part of a £162m investment in transforming cancer care for the 2.4 million people of Cheshire and Merseyside, a region where people are more likely to develop cancer than almost anywhere else in the country.
Preparatory work began onsite in late 2016 and formal construction got underway in 2017.
The new cancer hospital has 110 fully-single en-suite patient bedrooms which will reduce the risk of catching coronavirus. This is important because people with cancer can be at greater risk of becoming extremely unwell from the virus. There are also special isolation facilities for patients whose immune systems mean they are particularly vulnerable to infection.
Clatterbridge Cancer Centre – Liverpool will deliver a wide range of highly-specialist cancer care including pioneering chemotherapy, immunotherapy, gene therapy and radiotherapy. The new hospital has state-of-the-art facilities for bone marrow transplant, diagnostics and imaging, outpatients, daycase treatments, a Teenage & Young Adult Unit, clinical therapies, and a wide range of cancer information and support.
Being on site with Royal Liverpool University Hospital and the University of Liverpool medical school will have huge benefits for people with cancer, now and in the future. It will enhance care for the most complex patients – for example, those who have heart, lung and kidney conditions as well as cancer – by providing rapid access to medical and surgical specialties. Patients will also have access to leading-edge clinical trials of new cancer treatments.
The new hospital will become the main hub in The Clatterbridge Cancer Centre NHS Foundation Trust’s extensive network of treatment centres, including its Wirral and Aintree sites, hospitals across Cheshire and Merseyside and community settings including patients’ homes and workplaces.
Dr Liz Bishop, Chief Executive of The Clatterbridge Cancer Centre NHS Foundation Trust, said: “Clatterbridge Cancer Centre – Liverpool is the culmination of an eight-year vision for transforming cancer care in a region with one of the highest rates of cancer in the country. It brings state-of-the-art facilities and pioneering cancer treatments to Cheshire and Merseyside at a time when they are more vitally needed than ever.
“We are tremendously excited about opening Clatterbridge Cancer Centre – Liverpool. It has been a huge labour of love and I would like to pay tribute to our staff, the Laing O’Rourke site team, our suppliers, subcontractors and all the partners who have helped to bring it to fruition.”
Mayor of Liverpool Joe Anderson said: “The opening of the new Clatterbridge Cancer Centre is fantastic news for Liverpool and the region, and for everyone who will receive world-class treatment there.
“The building, the research and the care that will take place there is a tremendous boost to the city’s position as a world leader in medicine – and further underlines the growing international reputation of our multi-billion pound Knowledge Quarter, with the nearby Paddington Village also quickly taking shape.”